TGFB1 and atrial fibrillation: Previous studies have found that TGF-β1 overexpression in animal models [33,34,35] and AF patients [29,30] will lead to increased cardiac fibrosis, cardiac displacement, cardiac dysfunction, and fibrosis-related arrhythmia.